Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma : a translational analysis of the DEBIOC clinical trial

Scanlon, E, Lavery, A, Albraikat, M, Stevenson, L, Kennedy, C, Byrne, R, Walker, A, Mullan-Young, B, McManus, D T, Virdee, P S, Elhussein, L, Turbitt, J, Collinson, D, Miedzybrodzka, Z, Van Schaeybroeck, S, McQuaid, S, James, J A, Craig, S G, Blayney, J K, Petty, R D, Harkin, D P, Kennedy, R D, Eatock, M M, Middleton, M R, Thomas, A & Turkington, R C 2024, 'Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma : a translational analysis of the DEBIOC clinical trial', ESMO Open, vol. 9, no. 11, 103930. https://doi.org/10.1016/j.esmoop.2024.103930